The International Balzan Foundation has named University of Cambridge researcher and RNA silencing pioneer David Baulcombe a 2012 Balzan Prize winner.
Baulcombe was named a winner for his “fundamental contribution to the understanding of epigenetics and its role in cell and tissue development under normal and stressful conditions,” the foundation said.
The prize comes with a 750,000 Swiss franc ($790,000) award.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
